You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 250 No. 6, August 12, 1983 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of Different Types of Intrauterine Devices on the Risk of Pelvic Inflammatory Disease

David W. Kaufman, MS, ScD; Jane Watson, MS; Lynn Rosenberg, ScD; Susan P. Helmrich, MS; Donald R. Miller, MS; Olli S. Miettinen, MD; Paul D. Stolley, MD; Samuel Shapiro, MB, FRCP(E)

JAMA. 1983;250(6):759-762.


Abstract

A case-control study of 155 women with pelvic inflammatory disease (PID) and 305 controls with other conditions was carried out. Compared with other methods of contraception, the age-adjusted relative risk estimate for use of any intrauterine device (IUD) within one month of admission was 8.6 (95% confidence limits, 5.3 and 13.8); for past use, the estimate was 1.6 (confidence limits, 0.6 and 4.0). The estimated risk was highest for users of the Dalkon Shield (11 cases and two controls), lowest for users of copper-containing devices (40 cases and 34 controls), and intermediate for users of other IUDs, principally the Lippes Loop (32 cases and 23 controls). Compared with copper-containing IUDs, the relative risk estimate for the Dalkon Shield was 6.5 (confidence limits, 1.5 and 27.5). When the Dalkon Shield and copper-containing IUDs were compared, in turn, with the Lippes Loop, the estimated risk was increased for the former and reduced for the latter, but the differences were not statistically significant. Nine of the 11 cases using the Dalkon Shield (82%) had severe PID (diagnosed at surgery or because of purulent cervical discharge), compared with 12 of 40 copper device users (30%) and nine of 32 Lippes Loop users (28%). The risk of PID did not seem to be related to duration of use of any of the three IUDs. This study confirms that IUD use increases the risk of PID. It also suggests that the Dalkon Shield is more harmful than other devices.

(JAMA 1983;250:759-762)



Author Affiliations

From the Drug Epidemiology Unit, Boston University School of Medicine (Drs Kaufman, Rosenberg, and Shapiro, Mr Miller, and Mss Watson and Helmrich); the Department of Epidemiology, Harvard School of Public Health, Boston (Dr Miettinen); and the Section of General Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia (Dr Stolley).


Footnotes

Reprint requests to Drug Epidemiology Unit, Boston University School of Medicine, 1371 Beacon St, Brookline, MA 02146 (Dr Kaufman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reversible Contraception for the 1980s
Grimes
JAMA 1986;255:69-75.
ABSTRACT  

Intrauterine Devices and Pelvic Inflammatory Disease
Edelman et al.
JAMA 1984;251:1278-1278.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.